
When the IPO Window Becomes the Business Model: Lessons from the PharmEasy-Thyrocare Saga
PharmEasy’s acquisition of Thyrocare was meant to build India’s largest integrated digital healthcare platform. Instead, heavy debt and reliance on a delayed IPO exposed a fragile capital structure. The episode offers critical lessons for startups on financial discipline, sustainable growth, and the risks of depending on a single liquidity event.
Read more


























Most Commented